A major discovery in cancer investigation is emerging with the use of VHH fragments to reactivate dysfunctional p53. This vital malignant suppressor protein is frequently disabled in several forms of malignancies, https://socialmediatotal.com/story7028041/nanobodies-reactivate-the-p53-protein-new-promising-pathway-for-malignant-therapy